|Localized hypermutation and associated gene losses in legume chloroplast genomes|
AM Magee, S Aspinall, DW Rice, BP Cusack, M Sémon, AS Perry, ...
Genome research 20 (12), 1700-1710, 2010
|The epigenome as a therapeutic target in prostate cancer|
AS Perry, RWG Watson, M Lawler, D Hollywood
Nature Reviews Urology 7 (12), 668, 2010
|Nucleotide substitution rates in legume chloroplast DNA depend on the presence of the inverted repeat|
AS Perry, KH Wolfe
Journal of Molecular Evolution 55 (5), 501-508, 2002
|The emerging roles of DNA methylation in the clinical management of prostate cancer|
AS Perry, R Foley, K Woodson, M Lawler
Endocrine-related cancer 13 (2), 357-377, 2006
|Long noncoding RNAs and prostate carcinogenesis: the missing ‘linc’?|
AL Walsh, AV Tuzova, EM Bolton, TH Lynch, AS Perry
Trends in molecular medicine 20 (8), 428-436, 2014
|The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer|
TM Murphy, AS Perry, M Lawler
Endocrine-related cancer 15 (1), 11, 2008
|Healthy work: challenges and Apportunities to 2030|
H Vaughan-Jones, L Barham
British United Provident Association, 2009
|The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers|
R Foley, L Marignol, AZ Thomas, IM Cullen, AS Perry, P Tewari, ...
Cancer biology & therapy 8 (2), 118-124, 2009
|Noncoding RNAs in prostate cancer: the long and the short of it|
EM Bolton, AV Tuzova, AL Walsh, T Lynch, AS Perry
Clinical Cancer Research 20 (1), 35-43, 2014
|Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer|
AS Perry, G O'Hurley, OA Raheem, K Brennan, S Wong, A O'Grady, ...
International journal of cancer 132 (8), 1771-1780, 2013
|Epigenetics of malignant melanoma|
B Moran, R Silva, AS Perry, WM Gallagher
Seminars in cancer biology 51, 80-88, 2018
|No evidence of XMRV in Irish prostate cancer patients with the R462Q mutation|
F D'arcy, R Foley, A Perry, L Marignol, M Lawler, E Gaffney, RGW Watson, ...
European Urology Supplements 7 (3), 271, 2008
|In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer|
AS Perry, B Loftus, R Moroose, TH Lynch, D Hollywood, RWG Watson, ...
British journal of cancer 96 (10), 1587-1594, 2007
|MicroRNAs as putative mediators of treatment response in prostate cancer|
F O'kelly, L Marignol, A Meunier, TH Lynch, AS Perry, D Hollywood
Nature Reviews Urology 9 (7), 397, 2012
|Evolutionary re-organisation of a large operon in adzuki bean chloroplast DNA caused by inverted repeat movement|
AS Perry, S Brennan, DJ Murphy, TA Kavanagh, KH Wolfe
DNA research 9 (5), 157-162, 2002
|Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor|
SG Gray, AM Baird, F O'Kelly, G Nikolaidis, M Almgren, A Meunier, ...
International journal of molecular medicine 30 (6), 1505-1511, 2012
|IGFBP7 Promoter Methylation and Gene Expression Analysis in Prostate Cancer|
L Sullivan, TM Murphy, C Barrett, B Loftus, J Thornhill, M Lawler, ...
The Journal of urology 188 (4), 1354-1360, 2012
|The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date|
SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ...
BJU international 121 (5), 737-744, 2018
|Expert consensus document: semantics in active surveillance for men with localized prostate cancer—results of a modified Delphi consensus procedure|
SM Bruinsma, MJ Roobol, PR Carroll, L Klotz, T Pickles, CM Moore, ...
Nature reviews urology 14 (5), 312, 2017
|Improving multivariable prostate cancer risk assessment using the Prostate Health Index|
RW Foley, L Gorman, N Sharifi, K Murphy, H Moore, AV Tuzova, AS Perry, ...
BJU international 117 (3), 409-417, 2016